285 related articles for article (PubMed ID: 9656199)
21. Autologous bone marrow transplantation in relapsed non-Hodgkin's lymphoma.
De Ruysscher D; Spaas P
N Engl J Med; 1996 Apr; 334(15):990; author reply 991-2. PubMed ID: 8596608
[No Abstract] [Full Text] [Related]
22. [The treatment of relapses of non-Hodgkin's lymphomas].
Kindzel'skiĭ LP; Sivkovich SA
Vrach Delo; 1989 Jan; (1):56-8. PubMed ID: 2718448
[TBL] [Abstract][Full Text] [Related]
23. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
24. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
[TBL] [Abstract][Full Text] [Related]
25. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
26. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
Jost LM; Honegger HP; Stahel RA
Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881
[TBL] [Abstract][Full Text] [Related]
27. High-dose therapy with autologous stem-cell transplantation in aggressive non-Hodgkin's lymphoma.
Verdonck LF
J Clin Oncol; 1999 Sep; 17(9):3003. PubMed ID: 10627188
[No Abstract] [Full Text] [Related]
28. Treatment of relapses in aggressive non Hodgkin's lymphoma.
Bosly A
Bull Cancer; 2004; 91(7-8):E261-73. PubMed ID: 15381464
[TBL] [Abstract][Full Text] [Related]
29. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
[TBL] [Abstract][Full Text] [Related]
30. Non-Hodgkin's lymphoma: treatment of large cell lymphomas.
Armitage JO; Carde P; Wolf M
Rev Invest Clin; 1994 Apr; Suppl():83-8. PubMed ID: 7886316
[No Abstract] [Full Text] [Related]
31. [Recent progress in the treatment of malignant lymphoma].
Ogura M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
[TBL] [Abstract][Full Text] [Related]
32. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
[TBL] [Abstract][Full Text] [Related]
33. Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma.
Fitoussi O; Simon D; Brice P; Makke J; Scrobohaci ML; Bibi Triki T; Hennequin C; Fermé C; Gisselbrecht C
Bone Marrow Transplant; 1999 Oct; 24(7):747-55. PubMed ID: 10516678
[TBL] [Abstract][Full Text] [Related]
34. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
35. [Non Hodgkin's lymphoma--treatment of choice and the role of high dose chemotherapy].
Jurczak W; Nowak W; Wójcik M; Skotnicki A
Przegl Lek; 1999; 56 Suppl 1():80-9. PubMed ID: 10494188
[TBL] [Abstract][Full Text] [Related]
36. [Medicinal therapy of malignant lymphomas].
Aul C; Schroeder M; Giagounidis A
Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
[TBL] [Abstract][Full Text] [Related]
37. Treatment results of chemoradiation therapy for localized aggressive lymphomas: A retrospective 20-year study.
Yamashita H; Izutsu K; Nakamura N; Shiraishi K; Chiba S; Kurokawa M; Tago M; Igaki H; Ohtomo K; Nakagawa K
Ann Hematol; 2006 Aug; 85(8):523-9. PubMed ID: 16691398
[TBL] [Abstract][Full Text] [Related]
38. 4. Report on workshop: UICC workshop "Therapy of NHL in early stages". Part 2: Aggressive lymphomas.
Schmits R; Trümper L
Ann Hematol; 2001; 80 Suppl 3():B16-9. PubMed ID: 11757698
[No Abstract] [Full Text] [Related]
39. [Prognostic factors of invasive non-Hodgkin's lymphoma].
Yu H; Hong XN; Li J; Peng LP; Ye L
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284
[TBL] [Abstract][Full Text] [Related]
40. Autologous bone marrow transplantation in relapsed non-Hodgkin's lymphoma.
Atkins CD
N Engl J Med; 1996 Apr; 334(15):990; author reply 991-2. PubMed ID: 8596607
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
